bromocriptine has been researched along with cy 208-243 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peterson, MR; Robertson, HA; Worth, GG | 1 |
| Agid, Y; Emre, M; Lataste, X; Lees, A; Rascol, A; Rinne, UK | 1 |
| Andén, NE; Casas, M; Ferré, S; Grabowska-Andén, M; Herrera-Marschitz, M; Ungerstedt, U | 1 |
| Edwards, SR; Jackson, DM; Ross, SB | 1 |
| Jaton, AL; Karlsson, G; Vigouret, JM | 1 |
| Bédard, PJ; Boucher, R; Di Paolo, T; Gagnon, C; Gomez-Mancilla, B; Markstein, R | 1 |
| Bédard, PJ; Di Paolo, T; Gagnon, C; Gomez-Mancilla, B; Markstein, R | 1 |
1 trial(s) available for bromocriptine and cy 208-243
| Article | Year |
|---|---|
Effects of a selective partial D1 agonist, CY 208-243, in de novo patients with Parkinson disease.
Topics: Adult; Aged; Antiparkinson Agents; Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Indoles; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Phenanthridines; Receptors, Dopamine; Receptors, Dopamine D1 | 1992 |
6 other study(ies) available for bromocriptine and cy 208-243
| Article | Year |
|---|---|
Synergistic and persistent interaction between the D2 agonist, bromocriptine, and the D1 selective agonist, CY 208-243.
Topics: alpha-Methyltyrosine; Animals; Bromocriptine; Dopamine Agents; Drug Synergism; Indoles; Male; Methyltyrosines; Mice; Motor Activity; Phenanthridines; Receptors, Dopamine D1; Reserpine | 1992 |
Postsynaptic dopamine/adenosine interaction: I. Adenosine analogues inhibit dopamine D2-mediated behaviour in short-term reserpinized mice.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Behavior, Animal; Bromocriptine; Dopamine; Dose-Response Relationship, Drug; Indoles; Male; Mice; Motor Activity; Phenanthridines; Phenylisopropyladenosine; Receptors, Dopamine; Receptors, Dopamine D2; Reserpine; Sulpiride | 1991 |
Dopamine D2 agonist-induced behavioural depression is reversed by dopamine D1 agonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Dose-Response Relationship, Drug; Ergolines; Indoles; Male; Mice; Motor Activity; Phenanthridines; Quinpirole; Receptors, Dopamine | 1989 |
Dopamine D1- and D2-receptor interaction in turning behaviour induced by dopamine agonists in 6-hydroxydopamine-lesioned rats.
Topics: Animals; Benzazepines; Bromocriptine; Hydroxydopamines; Indoles; Male; Motor Activity; Oxidopamine; Phenanthridines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Substantia Nigra; Sulpiride | 1988 |
Effect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Bromocriptine; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Homovanillic Acid; Indoles; Locomotion; Macaca fascicularis; Motor Skills; Neurologic Examination; Parkinson Disease, Secondary; Phenanthridines; Psychomotor Performance; Receptors, Dopamine; Receptors, Dopamine D1 | 1993 |
Effect of adding the D-1 agonist CY 208-243 to chronic bromocriptine treatment of MPTP-monkeys: regional changes of brain dopamine receptors.
Topics: Animals; Autoradiography; Behavior, Animal; Brain Chemistry; Bromocriptine; Dopamine Agents; Dopamine Agonists; Female; Indoles; Macaca fascicularis; MPTP Poisoning; Neostriatum; Ovariectomy; Parkinson Disease, Secondary; Phenanthridines; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1995 |